Liang-In Lin

16PUBLICATIONS
25CO-AUTHORS
Haematological tumoursMolecular targetsGene and molecular therapyPredictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Sep 26, 2026
Chromosomal Heterogeneity and Enrichment of Mitotic Regulatory Programs Reveal a Therapeutic Vulnerability in Cytarabine-Resistant FLT3-ITD AML.

|Feb 17, 2026
Modulating metabolic signatures to mitigate cabozantinib resistance in FLT3-ITD acute myeloid leukemia cell models.

Yu-Hsuan Fu, Kit Man Ng, Chi-Yang Tseng

|Jul 10, 2025
Ropeginterferon alfa-2b as a promising alternative to conventional interferon in CDA type 1: a case report of two siblings.

Tyng-Wei Yang, Xavier Cheng-Hong Tsai, Yu-Hsuan Fu

|May 19, 2025
Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations.

Sao-Chih Ni, Chi-Yuan Yao, Xavier Cheng-Hong Tsai

|Oct 11, 2023
Anti-leukemia effects of omipalisib in acute myeloid leukemia: inhibition of PI3K/AKT/mTOR signaling and suppression of mitochondrial biogenesis.

Chi-Yang Tseng, Yu-Hsuan Fu, Da-Liang Ou

|Aug 09, 2023
Validation of the molecular international prognostic scoring system in patients with myelodysplastic syndromes defined by international consensus classification.

Wan-Hsuan Lee, Ming-Tao Tsai, Cheng-Hong Tsai

Pageof 3

Frequent Collaborators

5 joint publications

Da-Liang Ou

5 joint publications

Yu-Hsuan Fu

5 joint publications

Jeng-Wei Lu

4 joint publications

Hwei-Fang Tien